A perfect example of RIT's place
A blog reader has written of a family member who has recurrent follicular non-Hodgkin's lymphoma after having received Rituxan-CHOP. (This is a very common initial therapy for follicular non-Hodgkin's lymphoma.)
In my personal judgement as a patient, this appears to be the perfect place to consider radioimmunotherapy (RIT). The medical oncologist commonly will recommend another series of Rituxan-CHOP in this case or may now opt for maintenance Rituxan therapy.
This is the time for the patient to inisist upon a consultation with a physician experienced in RIT !
RIT has the proven effectiveness and, overall, the cost of RIT is no greater than the cost of recurrent series of chemotherapy and Rituxan---not even considering the "cost" in terms of adverse effects of medicine and potential lost time from work.
Mort